WNK2 and cancer: Salivary IL-6, as a pro-inflammatory cytokine, activates Janus kinases (JAK) and signal transducers and activators of transcription (STATs), which stimulate mitogen-activated protein kinase (MAPK), which activates cell proliferation and angiogenesis and supports cancer development.